Skip to main content
Premium Trial:

Request an Annual Quote

Myriad Genetics and Abbott Laboratories Unveil Pharmacogenetics Collaboration

NEW YORK, Jan. 7 (GenomeWeb News) -- Myriad Genetics of Salt Lake City, Utah, and Abbott Laboratories today unveiled a new pharmacogenetics program and announced the expansion of a collaboration between the two companies.

Financial details were not provided. However, Abbott will fund all research under this collaboration and will retain sole ownership of the results. Myriad will have first rights on any personalized medicine products for reference lab uses that may result, the company said in a statement.

The companies will collaborate on research to identify genetic variation within the general population around drug targets in variuous stages of development. Myriad will provide its high-throughput sequencing technologies and  mutation screening software to analyze samples from various populations to identify genetic polymorphisms.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.